Clinical Trials Logo

Clinical Trial Summary

Background: Early diagnosis of respiratory impairment in Post-Polio (PPS) patients may delay respiratory decline and future need of invasive respiratory aids.

Objectives: To compare pulmonary function measures, maximal respiratory pressure and activity levels and fatigue of respiratory muscles between patients with PPS and healthy controls.

Design: Cross-sectional study. Setting: Hadassah physical medicine and rehabilitation department, Jerusalem. Patients: Patients with PPS (N=12; 6 males; age 62.1±11.6 years) able to walk for 6 minutes without human assistance; age-matched healthy subjects (N=12; 4 males; age 62.2±6.5 years).

Intervention: None. Measurements: A body plethysmograph was used to quantify forced expiratory volume in the first second of a forced expiratory maneuver, vital capacity, slow vital capacity, Residual Volume (RV), Total Lung Capacity (TLC), and Thoracic Gas Volume (TGV). Also, RV to TLC ratio is calculated. A manometer was used to measure Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP). A spirometer was used to measure Maximal Voluntary Ventilation (MVV). Surface electromyography (sEMG) recorded diaphragmatic muscle activity during rest and while performing MVV.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03064711
Study type Interventional
Source Hadassah Medical Organization
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date January 2016

See also
  Status Clinical Trial Phase
Terminated NCT02176863 - Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome Phase 2/Phase 3
Active, not recruiting NCT03561623 - Spinal Cord Gray Matter Imaging in Post Polio Syndrome
Completed NCT02815878 - Enhance Wellness for Individuals With Long-Term Physical Disabilities N/A
Recruiting NCT05644522 - Nomad P-KAFO Study N/A
Completed NCT02801071 - L-Citrulline in Patients With Post-Polio Syndrome Phase 3
Completed NCT01537575 - Intravenous Immunoglobulins for Post-Polio Syndrome Phase 3
Active, not recruiting NCT02089880 - Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis N/A
Completed NCT01402570 - Glutathione and Health With Post-Polio Syndrome N/A
Completed NCT00231439 - Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) Phase 2/Phase 3